Literature DB >> 21103970

Role of the intestinal bile acid transporters in bile acid and drug disposition.

Paul A Dawson1.   

Abstract

Membrane transporters expressed by the hepatocyte and enterocyte play critical roles in maintaining the enterohepatic circulation of bile acids, an effective recycling and conservation mechanism that largely restricts these potentially cytotoxic detergents to the intestinal and hepatobiliary compartments. In doing so, the hepatic and enterocyte transport systems ensure a continuous supply of bile acids to be used repeatedly during the digestion of multiple meals throughout the day. Absorption of bile acids from the intestinal lumen and export into the portal circulation is mediated by a series of transporters expressed on the enterocyte apical and basolateral membranes. The ileal apical sodium-dependent bile acid cotransporter (abbreviated ASBT; gene symbol, SLC10A2) is responsible for the initial uptake of bile acids across the enterocyte brush border membrane. The bile acids are then efficiently shuttled across the cell and exported across the basolateral membrane by the heteromeric Organic Solute Transporter, OSTα-OSTβ. This chapter briefly reviews the tissue expression, physiology, genetics, pathophysiology, and transport properties of the ASBT and OSTα-OSTβ. In addition, the chapter discusses the relationship between the intestinal bile acid transporters and drug metabolism, including development of ASBT inhibitors as novel hypocholesterolemic or hepatoprotective agents, prodrug targeting of the ASBT to increase oral bioavailability, and involvement of the intestinal bile acid transporters in drug absorption and drug-drug interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21103970      PMCID: PMC3249407          DOI: 10.1007/978-3-642-14541-4_4

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  185 in total

1.  Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta.

Authors:  David J Seward; Albert S Koh; James L Boyer; Nazzareno Ballatori
Journal:  J Biol Chem       Date:  2003-04-28       Impact factor: 5.157

2.  A novel class of apical sodium co-dependent bile acid transporter inhibitors: the 1,2-benzothiazepines.

Authors:  Michael B Tollefson; Stephen A Kolodziej; Theresa R Fletcher; William F Vernier; Judith A Beaudry; Bradley T Keller; David B Reitz
Journal:  Bioorg Med Chem Lett       Date:  2003-11-03       Impact factor: 2.823

3.  Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition.

Authors:  Richard H Ho; Brenda F Leake; Richard L Roberts; Wooin Lee; Richard B Kim
Journal:  J Biol Chem       Date:  2003-12-02       Impact factor: 5.157

4.  Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein.

Authors:  Tineke Kok; Christian V Hulzebos; Henk Wolters; Rick Havinga; Luis B Agellon; Frans Stellaard; Bei Shan; Margrit Schwarz; Folkert Kuipers
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

Review 5.  The sodium bile salt cotransport family SLC10.

Authors:  Bruno Hagenbuch; Paul Dawson
Journal:  Pflugers Arch       Date:  2003-07-08       Impact factor: 3.657

6.  Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.

Authors:  B Ganesh Bhat; Stephen R Rapp; Judith A Beaudry; Nida Napawan; Dustie N Butteiger; Kerri A Hall; Christopher L Null; Yi Luo; Bradley T Keller
Journal:  J Lipid Res       Date:  2003-06-16       Impact factor: 5.922

7.  Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice.

Authors:  Paul A Dawson; Jamie Haywood; Ann L Craddock; Martha Wilson; Mary Tietjen; Kimberly Kluckman; Nobuyo Maeda; John S Parks
Journal:  J Biol Chem       Date:  2003-06-20       Impact factor: 5.157

Review 8.  Enterohepatic cycling of bilirubin as a cause of 'black' pigment gallstones in adult life.

Authors:  L Vítek; M C Carey
Journal:  Eur J Clin Invest       Date:  2003-09       Impact factor: 4.686

9.  SC-435, an ileal apical sodium co-dependent bile acid transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in guinea pigs.

Authors:  Kristy L West; Tosca L Zern; Dustie N Butteiger; Bradley T Keller; Maria Luz Fernandez
Journal:  Atherosclerosis       Date:  2003-12       Impact factor: 5.162

10.  A novel class of apical sodium-dependent bile acid transporter inhibitors: the amphiphilic 4-oxo-1-phenyl-1,4-dihydroquinoline derivatives.

Authors:  Hitoshi Kurata; Sayaka Suzuki; Yasuo Ohhata; Takuya Ikeda; Toru Hasegawa; Ken Kitayama; Toshimori Inaba; Keita Kono; Takafumi Kohama
Journal:  Bioorg Med Chem Lett       Date:  2004-03-08       Impact factor: 2.823

View more
  50 in total

1.  Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT.

Authors:  Fadi Annaba; Zaheer Sarwar; Ravinder K Gill; Amit Ghosh; Seema Saksena; Alip Borthakur; Gail A Hecht; Pradeep K Dudeja; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  Structural insights into the transport of small molecules across membranes.

Authors:  Nicholas Noinaj; Susan K Buchanan
Journal:  Curr Opin Struct Biol       Date:  2014-03-28       Impact factor: 6.809

3.  Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure.

Authors:  Matthew McMillin; Gabriel Frampton; Matthew Quinn; Samir Ashfaq; Mario de los Santos; Stephanie Grant; Sharon DeMorrow
Journal:  Am J Pathol       Date:  2015-12-09       Impact factor: 4.307

Review 4.  An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.

Authors:  Frank J Gonzalez; Changtao Jiang; Andrew D Patterson
Journal:  Gastroenterology       Date:  2016-09-14       Impact factor: 22.682

5.  Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats.

Authors:  Wen Zhao; Jeremiah D Zitzow; David J Ehresman; Shu-Ching Chang; John L Butenhoff; Jameson Forster; Bruno Hagenbuch
Journal:  Toxicol Sci       Date:  2015-05-21       Impact factor: 4.849

6.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Transmembrane domain II of the human bile acid transporter SLC10A2 coordinates sodium translocation.

Authors:  Hairat Sabit; Sairam S Mallajosyula; Alexander D MacKerell; Peter W Swaan
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

Review 8.  Effects of bile acids on neurological function and disease.

Authors:  Matthew McMillin; Sharon DeMorrow
Journal:  FASEB J       Date:  2016-07-28       Impact factor: 5.191

9.  Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity.

Authors:  Diana Vivian; Kunrong Cheng; Sandeep Khurana; Su Xu; Valerie Whiterock; Drew Witter; Kimberley A Lentz; Kenneth S Santone; Jean-Pierre Raufman; James E Polli
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

Review 10.  Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters.

Authors:  M Sawkat Anwer; Bruno Stieger
Journal:  Pflugers Arch       Date:  2013-10-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.